Ecron Acunova SWOT Analysis, Strategy, Revenues and Profits

• Publication date: November 2012
• Report size: 24 pages

Ecron Acunova (EA) is a full-service expert contract service organization (CRO) engaged in providing clinical development services to the pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. The organization offers end to end services for phase I - IV clinical research, which includes Clinical Data Management, PK/PD services, Clinical Trial Management, Bio availability and Bio equivalence Services, and Ce...

Ecron Acunova (EA) is a full-service expert contract service organization (CRO) engaged in providing clinical development services to the pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. The organization offers end to end services for phase I - IV clinical research, which includes Clinical Data Management, PK/PD services, Clinical Trial Management, Bio availability and Bio equivalence Services, and Central Lab. The organization is well recognized for its clinical research and has presence across Europe, Japan, India, China, Israel, Canada and the US. The research areas include Allergology, Gynaecology, Peripheral arterial diseases, Cardiovascular diseases Metabolic disorders, Psychiatry, Clinical immunology/infectiology, Nephrology, Pulmonology, Dermatology Neurology, Rheumatology, Diagnostic imaging, Nutrition Urology, Endocrinology, Oncology, Surgery, ENT, Gastroenterology and Ophthalmology. It has established its research facilities in Asia, and various parts of Europe and US. EA is headquartered in Bangalore, Karnataka, India

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about operations to identify potential customers, partners and suppliers. business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Drug Discovery And Development Industry in Germany

I - Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios

Clinical Trial in Germany

Germany Total Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : Germany

Germany Phase Ii Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : Germany

Germany Phase Iii Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : Germany

Germany Phase Iv Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : Germany

Germany Phase I Clinical Trials

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

• Industries : Drug Discovery and Development
• Countries : Germany